Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: Phospholipase activation and deacylation of specific-membrane phospholipids

The role of phospholipase (PLase) activation and lipid metabolism in lymphotoxin (LT)‐ and tumor necrosis factor (TNF)‐mediated destruction of murine L929 cells was examined. At the levels of LT and TNF employed, cell destruction began at 4–6 h and was 99% complete by 30 h. Cell membrane phospholipi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular physiology 1990-03, Vol.142 (3), p.469-479
Hauptverfasser: Knauer, Mary Fitzgerald, Longmuir, Kenneth J., Yamamoto, Robert S., Fitzgerald, Thomas P., Granger, Gale A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 479
container_issue 3
container_start_page 469
container_title Journal of cellular physiology
container_volume 142
creator Knauer, Mary Fitzgerald
Longmuir, Kenneth J.
Yamamoto, Robert S.
Fitzgerald, Thomas P.
Granger, Gale A.
description The role of phospholipase (PLase) activation and lipid metabolism in lymphotoxin (LT)‐ and tumor necrosis factor (TNF)‐mediated destruction of murine L929 cells was examined. At the levels of LT and TNF employed, cell destruction began at 4–6 h and was 99% complete by 30 h. Cell membrane phospholipids (PL), labelled in situ at the C2 position with 14C arachidonic acid, were analyzed by two‐dimensional thin‐layer chromatography and quantiated over a 30 h time course after LT or TNF treatment. The ratio of radiolabel incorporation relative to the actual amount of each PL present was determined by inorganic phosphate analysis. Radiolabelled arachidonic acid, eicosanoids, and neutral lipids were released into the medium prior to the onset of cell death (4–6 h) and continued to accumulate linearly throughout the destructive reaction. There was a quantitative relationship between the appearance of radiolabelled metabolites in the media and the loss of radiolabelled cellular PL. Cellular phosphatidylethanola‐mine was the primary PL deacylated by PLase action, showing a 75% reduction in radiolabel. The PLase inhibitors—quinacrine, hydrocortisone, dexamethasone, and indomethacin—were potent inhibitors of LT‐ and TNF‐mediated cell destruction, suggesting that selective deacylation of specific membrane PL by PLase activation is an important step in the events that lead to LT‐ and TNF‐mediated cellular destruction in vitro.
doi_str_mv 10.1002/jcp.1041420305
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79673478</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79673478</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4295-9ae77c1e0019d343c254df66a87dddb92f91cfc6efa6d739d6b51df3c5fcbf9b3</originalsourceid><addsrcrecordid>eNqFkUFv1DAQhS1EVZbClRuSL3BLa8dJvOYGERSqtqxUUI-WM7a1Lkmc2knp_ib-JE53uxUnTrY1732emYfQG0qOKSH5yQ0M6VLQIieMlM_QghLBs6Iq8-dokQQ0E2VBX6CXMd4QQoRg7BAd5pRwuiwW6M-FgbXqXeywt3g9darH7aYb1n70967Hqtd4nDofcG8g-OgitgrG9Ha9nsBorE0cwwSj8_2MANO2MRXxnRuD_4BXax8TrXWDigYnq7tTD9qZrI2CTasevXEw4KyDrDNdE1Rv8LB3Ox1foQOr2mhe784j9PPL5x_11-z8--m3-uN5BkUuykwowzlQQwgVmhUM8rLQtqrUkmutG5FbQcFCZayqNGdCV01JtWVQWmisaNgRer_lDsHfTmk82bk4z5U68lOUXFScFXyZhMdb4byZGIyVQ3CdChtJiZzTkSkd-ZROMrzdkaemM3ov38WR6u92dRVBtTbtAFx8ooqqZAmbdGKr--1as_nPr_KsXv3TQ7b1ujia-71XhV8yjcVLeX15Kusr8el6VV_KK_YXH7C90A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79673478</pqid></control><display><type>article</type><title>Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: Phospholipase activation and deacylation of specific-membrane phospholipids</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Knauer, Mary Fitzgerald ; Longmuir, Kenneth J. ; Yamamoto, Robert S. ; Fitzgerald, Thomas P. ; Granger, Gale A.</creator><creatorcontrib>Knauer, Mary Fitzgerald ; Longmuir, Kenneth J. ; Yamamoto, Robert S. ; Fitzgerald, Thomas P. ; Granger, Gale A.</creatorcontrib><description>The role of phospholipase (PLase) activation and lipid metabolism in lymphotoxin (LT)‐ and tumor necrosis factor (TNF)‐mediated destruction of murine L929 cells was examined. At the levels of LT and TNF employed, cell destruction began at 4–6 h and was 99% complete by 30 h. Cell membrane phospholipids (PL), labelled in situ at the C2 position with 14C arachidonic acid, were analyzed by two‐dimensional thin‐layer chromatography and quantiated over a 30 h time course after LT or TNF treatment. The ratio of radiolabel incorporation relative to the actual amount of each PL present was determined by inorganic phosphate analysis. Radiolabelled arachidonic acid, eicosanoids, and neutral lipids were released into the medium prior to the onset of cell death (4–6 h) and continued to accumulate linearly throughout the destructive reaction. There was a quantitative relationship between the appearance of radiolabelled metabolites in the media and the loss of radiolabelled cellular PL. Cellular phosphatidylethanola‐mine was the primary PL deacylated by PLase action, showing a 75% reduction in radiolabel. The PLase inhibitors—quinacrine, hydrocortisone, dexamethasone, and indomethacin—were potent inhibitors of LT‐ and TNF‐mediated cell destruction, suggesting that selective deacylation of specific membrane PL by PLase activation is an important step in the events that lead to LT‐ and TNF‐mediated cellular destruction in vitro.</description><identifier>ISSN: 0021-9541</identifier><identifier>EISSN: 1097-4652</identifier><identifier>DOI: 10.1002/jcp.1041420305</identifier><identifier>PMID: 2107184</identifier><identifier>CODEN: JCLLAX</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; Arachidonic Acid ; Arachidonic Acids - metabolism ; Biological and medical sciences ; Cell physiology ; Cell Survival - drug effects ; Dexamethasone - pharmacology ; Enzyme Activation ; Fundamental and applied biological sciences. Psychology ; Humans ; Hydrocortisone - pharmacology ; Indomethacin - pharmacology ; Lymphotoxin-alpha - pharmacology ; Membrane Lipids - metabolism ; Mice ; Molecular and cellular biology ; Phospholipases - antagonists &amp; inhibitors ; Phospholipases - metabolism ; Phospholipids - metabolism ; Quinacrine - pharmacology ; Responses to growth factors, tumor promotors, other factors ; Tumor Cells, Cultured ; Tumor Necrosis Factor-alpha - pharmacology</subject><ispartof>Journal of cellular physiology, 1990-03, Vol.142 (3), p.469-479</ispartof><rights>Copyright © 1990 Wiley‐Liss, Inc.</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4295-9ae77c1e0019d343c254df66a87dddb92f91cfc6efa6d739d6b51df3c5fcbf9b3</citedby><cites>FETCH-LOGICAL-c4295-9ae77c1e0019d343c254df66a87dddb92f91cfc6efa6d739d6b51df3c5fcbf9b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcp.1041420305$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcp.1041420305$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19653002$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2107184$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Knauer, Mary Fitzgerald</creatorcontrib><creatorcontrib>Longmuir, Kenneth J.</creatorcontrib><creatorcontrib>Yamamoto, Robert S.</creatorcontrib><creatorcontrib>Fitzgerald, Thomas P.</creatorcontrib><creatorcontrib>Granger, Gale A.</creatorcontrib><title>Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: Phospholipase activation and deacylation of specific-membrane phospholipids</title><title>Journal of cellular physiology</title><addtitle>J. Cell. Physiol</addtitle><description>The role of phospholipase (PLase) activation and lipid metabolism in lymphotoxin (LT)‐ and tumor necrosis factor (TNF)‐mediated destruction of murine L929 cells was examined. At the levels of LT and TNF employed, cell destruction began at 4–6 h and was 99% complete by 30 h. Cell membrane phospholipids (PL), labelled in situ at the C2 position with 14C arachidonic acid, were analyzed by two‐dimensional thin‐layer chromatography and quantiated over a 30 h time course after LT or TNF treatment. The ratio of radiolabel incorporation relative to the actual amount of each PL present was determined by inorganic phosphate analysis. Radiolabelled arachidonic acid, eicosanoids, and neutral lipids were released into the medium prior to the onset of cell death (4–6 h) and continued to accumulate linearly throughout the destructive reaction. There was a quantitative relationship between the appearance of radiolabelled metabolites in the media and the loss of radiolabelled cellular PL. Cellular phosphatidylethanola‐mine was the primary PL deacylated by PLase action, showing a 75% reduction in radiolabel. The PLase inhibitors—quinacrine, hydrocortisone, dexamethasone, and indomethacin—were potent inhibitors of LT‐ and TNF‐mediated cell destruction, suggesting that selective deacylation of specific membrane PL by PLase activation is an important step in the events that lead to LT‐ and TNF‐mediated cellular destruction in vitro.</description><subject>Animals</subject><subject>Arachidonic Acid</subject><subject>Arachidonic Acids - metabolism</subject><subject>Biological and medical sciences</subject><subject>Cell physiology</subject><subject>Cell Survival - drug effects</subject><subject>Dexamethasone - pharmacology</subject><subject>Enzyme Activation</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Hydrocortisone - pharmacology</subject><subject>Indomethacin - pharmacology</subject><subject>Lymphotoxin-alpha - pharmacology</subject><subject>Membrane Lipids - metabolism</subject><subject>Mice</subject><subject>Molecular and cellular biology</subject><subject>Phospholipases - antagonists &amp; inhibitors</subject><subject>Phospholipases - metabolism</subject><subject>Phospholipids - metabolism</subject><subject>Quinacrine - pharmacology</subject><subject>Responses to growth factors, tumor promotors, other factors</subject><subject>Tumor Cells, Cultured</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><issn>0021-9541</issn><issn>1097-4652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFv1DAQhS1EVZbClRuSL3BLa8dJvOYGERSqtqxUUI-WM7a1Lkmc2knp_ib-JE53uxUnTrY1732emYfQG0qOKSH5yQ0M6VLQIieMlM_QghLBs6Iq8-dokQQ0E2VBX6CXMd4QQoRg7BAd5pRwuiwW6M-FgbXqXeywt3g9darH7aYb1n70967Hqtd4nDofcG8g-OgitgrG9Ha9nsBorE0cwwSj8_2MANO2MRXxnRuD_4BXax8TrXWDigYnq7tTD9qZrI2CTasevXEw4KyDrDNdE1Rv8LB3Ox1foQOr2mhe784j9PPL5x_11-z8--m3-uN5BkUuykwowzlQQwgVmhUM8rLQtqrUkmutG5FbQcFCZayqNGdCV01JtWVQWmisaNgRer_lDsHfTmk82bk4z5U68lOUXFScFXyZhMdb4byZGIyVQ3CdChtJiZzTkSkd-ZROMrzdkaemM3ov38WR6u92dRVBtTbtAFx8ooqqZAmbdGKr--1as_nPr_KsXv3TQ7b1ujia-71XhV8yjcVLeX15Kusr8el6VV_KK_YXH7C90A</recordid><startdate>199003</startdate><enddate>199003</enddate><creator>Knauer, Mary Fitzgerald</creator><creator>Longmuir, Kenneth J.</creator><creator>Yamamoto, Robert S.</creator><creator>Fitzgerald, Thomas P.</creator><creator>Granger, Gale A.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199003</creationdate><title>Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: Phospholipase activation and deacylation of specific-membrane phospholipids</title><author>Knauer, Mary Fitzgerald ; Longmuir, Kenneth J. ; Yamamoto, Robert S. ; Fitzgerald, Thomas P. ; Granger, Gale A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4295-9ae77c1e0019d343c254df66a87dddb92f91cfc6efa6d739d6b51df3c5fcbf9b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Animals</topic><topic>Arachidonic Acid</topic><topic>Arachidonic Acids - metabolism</topic><topic>Biological and medical sciences</topic><topic>Cell physiology</topic><topic>Cell Survival - drug effects</topic><topic>Dexamethasone - pharmacology</topic><topic>Enzyme Activation</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Hydrocortisone - pharmacology</topic><topic>Indomethacin - pharmacology</topic><topic>Lymphotoxin-alpha - pharmacology</topic><topic>Membrane Lipids - metabolism</topic><topic>Mice</topic><topic>Molecular and cellular biology</topic><topic>Phospholipases - antagonists &amp; inhibitors</topic><topic>Phospholipases - metabolism</topic><topic>Phospholipids - metabolism</topic><topic>Quinacrine - pharmacology</topic><topic>Responses to growth factors, tumor promotors, other factors</topic><topic>Tumor Cells, Cultured</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Knauer, Mary Fitzgerald</creatorcontrib><creatorcontrib>Longmuir, Kenneth J.</creatorcontrib><creatorcontrib>Yamamoto, Robert S.</creatorcontrib><creatorcontrib>Fitzgerald, Thomas P.</creatorcontrib><creatorcontrib>Granger, Gale A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cellular physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Knauer, Mary Fitzgerald</au><au>Longmuir, Kenneth J.</au><au>Yamamoto, Robert S.</au><au>Fitzgerald, Thomas P.</au><au>Granger, Gale A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: Phospholipase activation and deacylation of specific-membrane phospholipids</atitle><jtitle>Journal of cellular physiology</jtitle><addtitle>J. Cell. Physiol</addtitle><date>1990-03</date><risdate>1990</risdate><volume>142</volume><issue>3</issue><spage>469</spage><epage>479</epage><pages>469-479</pages><issn>0021-9541</issn><eissn>1097-4652</eissn><coden>JCLLAX</coden><abstract>The role of phospholipase (PLase) activation and lipid metabolism in lymphotoxin (LT)‐ and tumor necrosis factor (TNF)‐mediated destruction of murine L929 cells was examined. At the levels of LT and TNF employed, cell destruction began at 4–6 h and was 99% complete by 30 h. Cell membrane phospholipids (PL), labelled in situ at the C2 position with 14C arachidonic acid, were analyzed by two‐dimensional thin‐layer chromatography and quantiated over a 30 h time course after LT or TNF treatment. The ratio of radiolabel incorporation relative to the actual amount of each PL present was determined by inorganic phosphate analysis. Radiolabelled arachidonic acid, eicosanoids, and neutral lipids were released into the medium prior to the onset of cell death (4–6 h) and continued to accumulate linearly throughout the destructive reaction. There was a quantitative relationship between the appearance of radiolabelled metabolites in the media and the loss of radiolabelled cellular PL. Cellular phosphatidylethanola‐mine was the primary PL deacylated by PLase action, showing a 75% reduction in radiolabel. The PLase inhibitors—quinacrine, hydrocortisone, dexamethasone, and indomethacin—were potent inhibitors of LT‐ and TNF‐mediated cell destruction, suggesting that selective deacylation of specific membrane PL by PLase activation is an important step in the events that lead to LT‐ and TNF‐mediated cellular destruction in vitro.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>2107184</pmid><doi>10.1002/jcp.1041420305</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9541
ispartof Journal of cellular physiology, 1990-03, Vol.142 (3), p.469-479
issn 0021-9541
1097-4652
language eng
recordid cdi_proquest_miscellaneous_79673478
source Wiley Online Library - AutoHoldings Journals; MEDLINE
subjects Animals
Arachidonic Acid
Arachidonic Acids - metabolism
Biological and medical sciences
Cell physiology
Cell Survival - drug effects
Dexamethasone - pharmacology
Enzyme Activation
Fundamental and applied biological sciences. Psychology
Humans
Hydrocortisone - pharmacology
Indomethacin - pharmacology
Lymphotoxin-alpha - pharmacology
Membrane Lipids - metabolism
Mice
Molecular and cellular biology
Phospholipases - antagonists & inhibitors
Phospholipases - metabolism
Phospholipids - metabolism
Quinacrine - pharmacology
Responses to growth factors, tumor promotors, other factors
Tumor Cells, Cultured
Tumor Necrosis Factor-alpha - pharmacology
title Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: Phospholipase activation and deacylation of specific-membrane phospholipids
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T02%3A32%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanism%20of%20human%20lymphotoxin%20and%20tumor%20necrosis%20factor%20induced%20destruction%20of%20cells%20in%20vitro:%20Phospholipase%20activation%20and%20deacylation%20of%20specific-membrane%20phospholipids&rft.jtitle=Journal%20of%20cellular%20physiology&rft.au=Knauer,%20Mary%20Fitzgerald&rft.date=1990-03&rft.volume=142&rft.issue=3&rft.spage=469&rft.epage=479&rft.pages=469-479&rft.issn=0021-9541&rft.eissn=1097-4652&rft.coden=JCLLAX&rft_id=info:doi/10.1002/jcp.1041420305&rft_dat=%3Cproquest_cross%3E79673478%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79673478&rft_id=info:pmid/2107184&rfr_iscdi=true